A drug rollout that officials hailed as a demonstration that the UK was still a “science superpower,” has reached only a ...
Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...
Patients with statin resistance do not experience symptoms, Le noted. Instead, the problem is that statins do not lower LDL-C levels as much as they typically do. Instead of a 50% reduction, people ...
HealthTab™ enters secondary-prevention care inside the NHS — a major expansion from screening into therapy-linked workflows. Integration with Ortus-iHealth connects HealthTab directly into hospital ...
Integration with Ortus-iHealth connects HealthTab directly into hospital clinical systems, positioning the platform as core infrastructure for NHS pharmacy-based care. Strengthens Avricore’s position ...
VANCOUVER, British Columbia, Nov. 27, 2025 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company " or “Avricore ”) is pleased to announce HealthTab™ is being deployed in a new pilot ...
(MENAFN- GlobeNewsWire - Nasdaq) Bringing Cholesterol-Lowering Injections to U.K. Community Pharmacies HealthTabTM enters secondary-prevention care inside the NHS - a major expansion from screening ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback